Cambridge, UK, 25th February 2020 / Sciad Newswire / One Nucleus is pleased to announce the launch of a new careers conference in Cambridge for students, employers and employees in the life sciences industry: “Building Life Science Adventures: A Conference on Creating the Best Careers and Teams.” The one-day event will be a chance to fill knowledge gaps and share best practice amongst academia and industry.
The conference will take place on Thursday 19th March 2020 from 09:00 - 16:00 at Anglia Ruskin University, Cambridge. With an expert…
Cambridge UK: 26 February 2020: Cerba Research has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs both of the Partner and the interests of One Nucleus members.Sofie Vandevyver, Head of Business Operations & Marketing, Cerba Research declared ‘we are proud of having formed this exciting new alliance with One Nucleus. We are confident this collaboration will allow us to bring people together and drive our leadership position within the field of precision medicine.’
Tony Jones, CEO of One Nucleus expands further ‘…
The EZ PREP efficiently isolate highly purified peripheral blood mononuclear cells from AMSBIO is designed to efficiently isolate highly purified peripheral blood mononuclear cells (PBMCs) from fresh whole blood products by density gradient centrifugation.The unique EZ PREP tube design provides greater visibility of your target cell population, allowing you to maximise your recovery of mononuclear cells. As a result, PBMCs are immediately available for downstream applications such as flow cytometry, culture, and/or DNA/RNA isolation.By making targeting and…
Cambridge and Leeds, UK, 25th February 2020 / Sciad Newswire / Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies.
The aim of the partnership is to discover a drug that inhibits the protease target, activated Factor XII. This coagulation factor is implicated in the formation of pathological clots, but not the stemming of bleeding, so…
Arecor Achieves Second License Milestone Payment from Global Pharmaceutical Partner
Arecor formulated biosimilar product progressing through clinical studies
Cambridge, UK., 25 February 2020: Arecor Ltd (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has achieved an important second, contractual milestone with one of its pharmaceutical partners. The first milestone was triggered in October 2017 following the signature of a license agreement between the parties.
In accordance with the license agreement…
Colleagues from TTP will be supporting and attending this one-day matchmaking event - do not miss it.
Information from the organisers: Imperial College London, NIHR and the NHS
PROBLEM
Less than 1% of proposed Biomarkers achieve clinical adoption and there is a wide gulf between those published in academic journals and those being translated onto scalable platforms that can be integrated into healthcare systems.
Earlier consideration of Biomarker platform should improve the efficiency and robustness of the research and enhance the likelihood
of the end product being clinically useful. This…
Air Liquide are pleased to announce the introduction of their new e-Mixture guide. It’s a familiar problem for laboratory technicians: you need a particular gas mixture – perhaps for calibration - but you don’t know exactly what data you need to provide to be sure that the mixture complies with the correct specifications. Not only that, the cost or delivery deadline might not be immediately clear. Air Liquide’s new e-Mixture Guide offers a ready-made answer to all these questions.The e-Mixture guide is a smart, powerful and user-friendly online tool, which guides customers…
Following a year of strong growth and successful acquisitions, Entrust People and SCI Search & Selection are merging to become Entrust Resource Solutions.
This new brand better represents the future of our group of recruitment consultancies and is a massive step towards us realising our vision of providing the very best, fully accountable, bench to board talent solution.
Our merger will enable us to better serve our clients and candidates as one larger, consolidated team strategically positioned in thriving life science hubs across the UK: Dundee, Northwich and our executive search brand…
The next SysMIC Module 1 course will start on Monday 27th April 2020
SysMIC was developed with BBSRC funding and provides introductory and advanced training in mathematics, statistics and computing for bioscientists. SysMIC is a comprehensive online course in interdisciplinary skills in the life sciences with over 2,000 participants enrolling since its beginning in 2013.
Key topics are:
• Network biology
• Mechanistic modeling, and
• Data analysis
Participants will gain an understanding of:
• Programming in Python, MATLAB and R
• Analysing, modelling and simulating biological systems
•…
Cambridge, UK, 13th February 2020 / Sciad Newswire / Domainex Ltd is pleased to announce the appointment of Dr Tom Mander as Chief Executive Officer. Dr Mander will take over when Dr Trevor Perrior retires from the role in April 2020. Tom has nearly 30 years of experience in small-molecule drug discovery, and joined Domainex as Chief Operating Officer in March 2015 with a mandate to achieve organic expansion of the drug discovery service business of the company.
Trevor Perrior, CEO of Domainex, said, “I am very pleased that Tom has agreed to take over as Chief Executive. Tom joined the…